LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE. Mediterr J Hematol Infect Dis 2011, 3 (1), e2011021. https://doi.org/10.4084/mjhid.2011.021.